BRIEF published on 07/25/2024 at 22:03, 8 months 12 days ago Vitruvia Medical AG: Half-Year Results as of June 30, 2024 Financial Performance Half-year Results 2024 Forecast Sales Targets Vitruvia Medical AG
BRIEF published on 07/25/2024 at 22:03, 8 months 12 days ago Vitruvia Medical AG : Résultats semestriels au 30 juin 2024 Résultats Semestriels Performance Financière Prévisions 2024 Objectifs De Vente Vitruvia Médical SA
PRESS RELEASE published on 07/25/2024 at 21:58, 8 months 12 days ago EQS-Adhoc: Vitruvia Medical AG: Half yearly results as per June 30th, 2024 Vitruvia Medical AG reports half-year results in line with expectations for the first half of 2024, confirming full-year forecast. Positive outlook with expected sales around EUR 2.0 million Sales Forecast Earnings Half-year Results Vitruvia Medical AG
BRIEF published on 05/01/2024 at 08:41, 11 months 6 days ago Vitruvia Medical AG Announces Improved Year-End Financial Results for 2023 Financial Results Revenue Growth 2024 Outlook Vitruvia Medical AG EBITA Improvement
BRIEF published on 05/01/2024 at 08:41, 11 months 6 days ago Vitruvia Medical AG annonce de meilleurs résultats financiers de fin d'année pour 2023 Résultats Financiers Perspectives 2024 Hausse Des Revenus Vitruvia Médical SA Amélioration De L'EBITA
PRESS RELEASE published on 05/01/2024 at 08:36, 11 months 6 days ago EQS-Adhoc: Vitruvia Medical AG: Year End results as of December 31, 2023 Vitruvia Medical AG reports Year End results for 2023 with revenue and earnings growth. Financial performance overview and outlook for LT technologies for 2024 Revenue Growth Financial Performance Vitruvia Medical AG Year End Results LT Technologies
PRESS RELEASE published on 09/29/2023 at 13:15, 1 year 6 months ago Vitruvia Medical AG: Consolidated interim results as per June 30th,2023
PRESS RELEASE published on 09/29/2023 at 12:15, 1 year 6 months ago EQS-Adhoc: Vitruvia Medical AG: Consolidated interim results as per June 30th,2023
PRESS RELEASE published on 07/28/2023 at 08:17, 1 year 8 months ago Vitruvia Medical AG: Shareholders approved all proposals at the Annual General Meeting of Shareholders
PRESS RELEASE published on 06/25/2023 at 09:59, 1 year 9 months ago EQS-Adhoc: Vitruvia Medical AG: Annual results as of 31.12.2022 and outlook 2023
Published on 04/07/2025 at 14:30, 1 hour 53 minutes ago Newsmax Enters into Standby Equity Purchase Agreement of Up to $1.2 Billion With Yorkville Advisors
Published on 04/07/2025 at 14:30, 1 hour 53 minutes ago Sparta Provides Update on Delay in Filing Annual Financial Statements
Published on 04/07/2025 at 14:00, 2 hours 23 minutes ago NOA Lithium Advances Towards 2025 Water Exploration at Rio Grande Project
Published on 04/07/2025 at 14:00, 2 hours 23 minutes ago Rio Grande Resources Announces the Successful Completion of Sampling and Field Campaign at the Winston Gold-Silver Project
Published on 04/07/2025 at 15:27, 55 minutes ago Form 8.3 - The Vanguard Group, Inc.: Qualcomm Incorporated
Published on 04/07/2025 at 15:25, 57 minutes ago Form 8.3 - The Vanguard Group, Inc.: American Axle & Manufacturing Holdings, Inc.
Published on 04/07/2025 at 15:24, 58 minutes ago Form 8.3 - The Vanguard Group, Inc.: TI Fluid Systems plc
Published on 04/07/2025 at 15:24, 58 minutes ago Personnel changes on the Supervisory Board of KION GROUP AG ensure continuity
Published on 04/07/2025 at 07:01, 9 hours 22 minutes ago bioMérieux obtient le marquage CE pour LUMED™ APSS™, une solution logicielle de pointe pour aider à prendre des décisions en matière de bon usage des antibiotiques
Published on 04/07/2025 at 07:01, 9 hours 22 minutes ago bioMérieux obtains CE-marking for LUMED™ APSS™, a cutting-edge software solution to aid medical decision-making in Antimicrobial Stewardship
Published on 04/04/2025 at 19:18, 2 days 21 hours ago Mersen: Number of shares and voting rights as of March 31, 2025
Published on 04/04/2025 at 19:18, 2 days 21 hours ago Mersen : nombre d'actions et de droits de vote au 31 mars 2025
Published on 04/04/2025 at 18:17, 2 days 22 hours ago Reporting on share buyback transactions carried out between March 31 and April 3, 2025
